Partial Thromboplastin Time (PTT)
The activated partial thromboplastin time (aPTT) is a test that measures the length of time it takes to form a fibrin clot in a blood specimen using the “intrinsic” coagulation pathway. Fibrin clots are formed when damage to tissues or the vascular system occurs. Many coagulation factors, such as Factor VIII and X, contribute to the clotting of blood and each factor is needed for the others to function correctly. Without clot formation, excessive bleeding could occur and could be fatal without treatment. Prolonged time of clot formation has many causes such as factor deficiency, vitamin K deficiency, or disseminated intravascular coagulation (DIC). Prolongations are also caused by circulating inhibitors such as lupus anticoagulant or when the patient is on anticoagulant therapy. There are also genetic disorders such as hemophilia, von Willebrand disease, or specific coagulation factor deficiencies that will lead to a deficient clotting process and prolong the aPTT. The most common use of the activated partial thromboplastin time is to monitor patients on heparin therapy. Heparin is given to patients when the risk of internal clotting or DIC is high. Heparin enhances the normal anticoagulant processes in the body thus preventing or greatly delaying blood clotting. Heparin has been seen to be efficient only at certain levels and the aPTT can aid the physician in dosage recommendations.
- To monitor anti-clotting therapy treatment
- As an aid in diagnosis of deficiency of coagulation factor or abnormality with the intrinsic pathway
- As an aid in diagnosis of clotting disorders related to lupus anticoagulant and other anti-phospholipid antibodies.
- As an aid in diagnosis of other clotting disorders such as von Willebrand disease, disseminated intravascular coagulation (DIC) and hemophilia A and B
- As an aid in diagnosis of pregnancy complication due to increased clotting tendency
Increased in (prolonged):
- Deficiency of any coagulation factor except Factors XIII and VII
- Presence of a nonspecific inhibitor
- Specific coagulation factor inhibitor
- von Willebrand disease (PTT may also be normal)
- Hemophilia A and B
- Disseminated intravascular coagulation (DIC)
- Use of some drugs: heparin, direct thrombin inhibitor, warfarin/coumadin
- Lupus anticoagulant and other anti-phospholipid antibodies
Decreased in:
- Hypercoagulable states due to changes in factor levels
- Increased blood level of Factor VIII
30 - 45 seconds
Panic:greater than or equal to 60 seconds
Plasma Citrate (Light Blue).
Stability
- Ambient: 24 hours
- Refrigerated: 3-5 days
- Frozen: 14 days
- Chest. 2004;126:188S. [PMID: 15383472]
- Thromb Haemost. 2004;91:1137. [PMID: 15175800]
- Clin Lab Haematol. 2006;28:105. [PMID: 16630214]
- Jacobs DS and DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
- George Fritsma KD. Hematology, Clinical Principles and Applications, 3rd Edition. St. Louis: Saunders Elsevier (2007).
- Activated Partial Thromboplastin Time (APTT), Plasma. In Mayo Interpretive Handbook.Rochester: Mayo Medical Laboratories (2009).